Contribution of Women Scientists to Pharmacology: A Historical Perspective

Contribution of Women Scientists to Pharmacology: A Historical Perspective

The article highlights the contributions of a few prominent women scientists to the science of pharmacology. These women,some of whom were from other scientific fields, contributed significantly to our understanding of pharmacology. This was achieved in an era in which pharmacology was a more or less male dominated field. Even though it is easier for women to enter scientific fields nowadays, t...

Spermatozoa: A Historical Perspective

The 100,000th scientific article on the subject of spermatozoa was recently published. Many studies have evaluated the characteristics of this important cell leading to great discoveries. Since its first observation and description in 1677, many important characteristics have been described regarding this highly fascinating gamete. In this review, our objective has been to provide a historical ...

The European Contribution to the Surgical Management of Spinal Cord Injury: An Historical Perspective

European scientists gave a fundamental contribution to a better understanding of the pathophysiology of spinal cord injury (SCI), and consequently defined the bestsuited treatment for this disease. The historical course of the management of SCI during the last two centuries goes through intuitive open-minded practicioners, physicians, neurologists, orthopedics, and neurosurgeons, which lived an...

Description of the human races: A historical perspective

New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”

New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom.